The Parkwalk Opportunities EIS Fund invests in innovative British high-growth technology companies, seeking capital appreciation with the added advantages to investors of the tax reliefs offered under the Enterprise Investment Scheme (EIS).
The Parkwalk Opportunities EIS Fund is open to investors all year.More
In conjunction with Cambridge Enterprise, the University’s TTO, Parkwalk manage the University of Cambridge Enterprise Funds, allowing alumni and supporters of the University unique access to deal-flow.

Fund V closed to investors in January 2017. More

In conjunction with Oxford University Innovation, the University’s TTO, Parkwalk manage the University of Oxford Innovation Funds, allowing alumni and supporters of the University of Oxford unique access to deal-flow.

Fund IV opened to investors in November 2017.More

In conjunction with the University’s Division of Research and Enterprise Development (‘RED’), Parkwalk manage the University of Bristol Enterprise Funds, offering unique access to deal-flow.

Fund II closed to investors in June 2017.More

About Parkwalk

Parkwalk manage a series of EIS Funds that invest in innovative, high-growth companies with strong IP backing their commercialisation. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at 31 July 2017 the combined group has net assets of £1.4bn, third-party funds under management of more than £200m and currently has a market capitalisation of c.£1.5bn.

Parkwalk has won multiple awards, including Investment Week ‘Best EIS Generalist‘ award 2016/17 and ‘Best EIS Fund‘ 2015/16; the EIS Association ‘Best Fund Manager 2016’, ‘Best Exit of 2016‘ and ‘Best Exit of 2014‘ awards and the Growth Investor ‘Best Exit 2015‘ and has been named by Crunchbase as one of the UK’s top 10 most active technology investors annually since 2014.

Our flagship Opportunities EIS Fund is open to investors all year, and invests in a minimum of five underlying investee companies per investor, and those companies range across the growth curve from early-stage through to AIM-listed, creating a diverse portfolio of sectors and business development stages, with capital raised used for development, commercialisation, scale-up and growth.

Parkwalk also manage a series of earlier-stage EIS Funds in conjunction with some of the world’s most highly regarded research institutes, including the University of Cambridge Enterprise Funds, the University of Oxford Innovation Funds, and the University of Bristol Enterprise Funds; these funds allow our investors access to some of the world’s highest calibre discoveries and IP.

All of Parkwalk’s fully-invested Funds are currently valued at a premium to original investment cost (inclusive of fees and tax reliefs).

Parkwalk EIS Funds

Parkwalk Opportunities EIS Fund
Parkwalk Funds seek to generate multiple returns by investing across a portfolio of companies whose proprietary IP or know-how originated from UK R&D intensive institutions and Universities, whilst providing significant tax reliefs to the individual investor through the Enterprise Investment Scheme.
Parkwalk’s current portfolio consists of over 75 companies. The portfolio companies have raised in excess of £600m of funding between them since 2010, employ over 1,000 people in the knowledge intensive economy and over 600 patents protect their technology, processes and freedom to operate.

  • sector diversification of investee companies
  • investments range from early stage through to AIM-listed
  • positive reviews by Allenbridge TSR and Churchill TER
  • click here to email the funds team to request further information
University of Cambridge Enterprise Fund V
University of Oxford Innovation Fund IV
University of Bristol Enterprise Fund II
Exits and IPOs

Parkwalk Recent Investments

Parkwalk Funds seek capital appreciation to generate multiple returns by investing across a portfolio of companies whose proprietary IP or know-how originated from UK Universities, whilst providing significant tax reliefs to the individual investor through the Enterprise Investment Scheme.

 

Email Signature Logos